The Delivery of α1-Antitrypsin Therapy Through Transepidermal Route: Worthwhile to Explore
Human α1-antitrypsin (AAT) is an abundant acute phase glycoprotein expressing anti-protease and immunomodulatory activities, and is used as a biopharmaceutical to treat patients with inherited AAT deficiency. The pleiotropic properties of AAT provide a rationale for using this therapy outside of inh...
Príomhchruthaitheoirí: | , , , , , , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Frontiers Media S.A.
2020-07-01
|
Sraith: | Frontiers in Pharmacology |
Ábhair: | |
Rochtain ar líne: | https://www.frontiersin.org/article/10.3389/fphar.2020.00983/full |